Innovation or Danger: Hemp-Derived Cannabinoids + Delta 8


The 2018 U.S. Farm Bill protects a particular set of cannabinoids – the chemical compounds derived from the hemp variety of the Cannabis sativa plant. These cannabinoids are legal as long as federal and state regulations are adhered to. The most famous of these cannabinoids is CBD and of late, so is delta-8 THC. Although legal, it’s important for consumers to be aware that delta-8 THC products have not been evaluated or approved by the FDA. 

CannabizMD Founder/CEO Jacquie Cohen Roth, MS, moderates the webinar “Innovation or Danger: Hemp-Derived Cannabinoids + Delta 8” with cannabis industry for a discussion with cannabis industry experts Matthew Mintz, MD, FACP, Dr. Linda Klumpers, PhD, and Matthew S Schweber exploring hemp-derived cannabinoids including their potential as a wellness product and disease treatment. Join them on June 22, 20122, 7 pm – 8 pm EST. Tickets are free, underscoring a critical focus on consumer safety and assurance of cannabis industry best practices.

Previous articleInnovation in Medical Cannabis: Data + Technology – March 10, 2022